Changes in peripheral cholinergic systems following development of tolerance to the anticholinesterase diisopropylfluorophosphate.
D000818:Animals; D001921:Brain / Q000201:enzymology; D002217:Carbachol / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D003964:Diaphragm / Q000201:enzymology; D004361:Drug Tolerance; D004912:Erythrocytes / Q000201:enzymology; D007082:Ileum / Q000201:enzymology; D007531:Isoflurophate / Q000494:pharmacology*; D008297:Male; D009020:Morphine / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D010525:Peripheral Nerves / Q000187:drug effects*; D010791:Phrenic Nerve / Q000201:enzymology; D051381:Rats; D013997:Time Factors; D014403:Tubocurarine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D007531:Isoflurophate; D009020:Morphine; D002217:Carbachol; D014403:Tubocurarine